Gene · 4600
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. | PLoS Negl Trop Dis | 2022 | 35622847 | PubTator, text mining | PubMed |
| Identifying Methylation Signatures and Rules for COVID-19 With Machine Learning Methods. | Front Mol Biosci | 2022 | 35620480 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma. | Front Immunol | 2022 | 35619698 | PubTator, text mining | PubMed |
| Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019. | Eur J Pharmacol | 2022 | 35618037 | PubTator, text mining | PubMed |
| RNA-Seq of amniotic fluid cell-free RNA: a discovery phase study of the pathophysiology of congenital cytomegalovirus infection. | Am J Obstet Gynecol | 2022 | 35609640 | PubTator, text mining | PubMed |
| Bisphenol a exposure decreases learning ability through the suppression of mitochondrial oxidative phosphorylation in the hippocampus of male mice. | Food Chem Toxicol | 2022 | 35598803 | PubTator, text mining | PubMed |
| Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques. | Cell Rep | 2022 | 35594870 | PubTator, text mining | PubMed |
| Potential of Endogenous Oxytocin in Endocrine Treatment and Prevention of COVID-19. | Front Endocrinol (Lausanne) | 2022 | 35592777 | PubTator, text mining | PubMed |
| Pseudorabies virus tegument protein UL13 recruits RNF5 to inhibit STING-mediated antiviral immunity. | PLoS Pathog | 2022 | 35584187 | PubTator, text mining | PubMed |
| Identification of candidate genes associated with bacterial and viral infections in wild boars hunted in Tuscany (Italy). | Sci Rep | 2022 | 35581286 | PubTator, text mining | PubMed |
| Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons. | Front Immunol | 2022 | 35572537 | PubTator, text mining | PubMed |
| Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy. | Mol Ther Oncolytics | 2022 | 35572196 | PubTator, text mining | PubMed |
| Insight into Spodium-π Bonding Characteristics of the MX2⋯π (M = Zn, Cd and Hg; X = Cl, Br and I) Complexes-A Theoretical Study. | Molecules | 2022 | 35566234 | PubTator, text mining | PubMed |
| Gene Interaction Network Analysis Reveals IFI44L as a Drug Target in Rheumatoid Arthritis and Periodontitis. | Molecules | 2022 | 35566100 | PubTator, text mining | PubMed |
| Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma. | Cancers (Basel) | 2022 | 35565392 | PubTator, text mining | PubMed |
| RNA Microarray-Based Comparison of Innate Immune Phenotypes between Human THP-1 Macrophages Stimulated with Two BCG Strains. | Int J Mol Sci | 2022 | 35562916 | PubTator, text mining | PubMed |
| Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants. | Nat Commun | 2022 | 35562337 | PubTator, text mining | PubMed |
| Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells. | Gene | 2022 | 35550407 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Intrinsic features of Zika Virus non-structural proteins NS2A and NS4A in the regulation of viral replication. | PLoS Negl Trop Dis | 2022 | 35522620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4600/papers?page=32